Tafluprost ethyl amide

• CAT Number: R067437
• CAS Number: 1185851-52-8
• Molecular Formula: C24H33F2NO4
• Molecular Weight: 437.528
• Purity: ≥95%
• Storage: -20°C
• IUPAC Name: (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]-N-ethylhept-5-enamide
• InChI: InChI=1S/C24H33F2NO4/c1-2-27-23(30)13-9-4-3-8-12-19-20(22(29)16-21(19)28)14-15-24(25,26)17-31-18-10-6-5-7-11-18/h3,5-8,10-11,14-15,19-22,28-29H,2,4,9,12-13,16-17H2,1H3,(H,27,30)/b8-3-,15-14+/t19-,20-,21+,22-/m1/s1
• InChIKey: VJZKLIPANASSBD-MSHHKXPZSA-N
• SMILES: CCNC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC=C2)(F)F)O)O

Tafluprost ethyl amide(CAT: R067437) is a chemical compound that may have relevance in pharmaceutical and medicinal chemistry. Its action method involves its potential use as an intermediate or analog in the synthesis of organic molecules, possibly for drug development or research purposes. Tafluprost is a prostaglandin analog used in the treatment of glaucoma and ocular hypertension, and Tafluprost ethyl amide may be related to the modification or synthesis of compounds within this class for potential pharmaceutical use.

Reference

1.Woodward, D.F.,Krauss, A.H.P.,Chen, J., et al. The pharmacology of Bimatoprost (Lumigan™). Survey of Ophthalmology 45, S337-S345 (2001).